MediciNova Inc reports results for the quarter ended in September - Earnings Summary

Medicinova

11/11/2022 03:57

* MediciNova Inc  MNOV.OQ  reported a quarterly adjusted
loss of 7
cents​​ per share for the quarter ended in September. The mean
expectation of three analysts for the quarter was for a loss
of 9 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * MediciNova Inc's reported EPS for the quarter was a loss
of 7
cents​.
    * The mean earnings estimate of analysts had risen by
about 20.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * MediciNova Inc shares had fallen by 2.3% this quarter and
lost 20.9% so far this year.
    * The company reported a quarterly loss of $3.65 million.
    * Wall Street's median 12-month price target for MediciNova
Inc is
$6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
11 at 03:57 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.09          -0.07          Beat
 Jun. 30 2022      -0.09          -0.08          Beat
 Mar. 31 2022      -0.09                         
 Dec. 31 2021      -0.09          -0.04          Beat